The Yellow Wall

A wall of new research in women’s health

Each card is one new study, survey or opinion, and who paid for it.

  • Independent research
  • Paid for by a company
  • Opinion
A woman's hand turning freshly printed pages on a sunlit wooden table, beside an open notebook and a cup of chai
20 cards
#20
Body & timing
11,925

older women in four studies: the stronger the blood protein signature of menopause, the more cognitive ageing and dementia risk. The protein changes tracked hormones more than age. It is a link, not a test or a cause.

Peer-reviewed
#18
The debate · Opinion

A reader replies to STAT's perimenopause op-ed

The letter agrees hype is a problem, but cites brain-imaging research, Menopause Society guidance and newer hormone therapy evidence, and calls the op-ed's narrow symptom list outdated.

Opinion
#17
Spotting it
71%

of Flo app users surveyed in 158 countries recognised hot flashes as a sign of perimenopause. Fatigue was the symptom women aged 35 and over reported most (83%), yet only 64% recognised it.

Peer-reviewed
#16
Getting care
62%

of 32,518 women surveyed in underprivileged communities in India did not know treatment for menopause was available.

Peer-reviewed
#14
The debate · Opinion

“The perimenopause movement sells women the lie that they are ruled by their hormones”

Two Georgetown researchers argue many midlife symptoms blamed on perimenopause may simply be ageing or stress, and that the hormone story sells products and casts women as ruled by hormones.

Opinion
#13
At work
47%

of 8,062 women surveyed, mostly in the US, UK and Australia, said perimenopause or menopause symptoms disrupted their work performance.

Brand survey
#12
Spotting it
1 in 3

lived with symptoms for more than six months before realising they were in perimenopause.

Brand survey
#11
At work
67%

of UK working women aged 40 to 60 who have had menopause symptoms say those symptoms had a mostly negative effect on them at work.

Expert body survey
#10
The debate · Opinion

“Out of Touch on Menopause: Experts Respond to The Lancet's 'Over-Medicalization' Claims”

Writing for 250+ clinicians, ob-gyn Mary Claire Haver argues The Lancet's 2024 series relied on outdated data, played down symptoms and undersold hormone therapy.

Opinion
#9
Getting care
40%

were told their symptoms were just part of ageing, the most common pushback women heard from practitioners, friends or family.

Brand survey
#8
Getting care
35.5%

of 76 women at a Chennai hospital had heard of HRT, even though 82.9% had heard of menopause.

Peer-reviewed
#7
At work
56%

said their symptoms left them less motivated at work. Anxiety or low mood is now the symptom women most often name as affecting them, ahead of hot flashes.

Brand survey
#6
Body & timing
4.7%

of rural women aged 30 to 39 in India's national health survey had already reached menopause, against 2.6% of urban women. The figures include menopause after hysterectomy.

Peer-reviewed
#5
The debate · Opinion

“What the menopause marketers won't tell you: ageing is to be celebrated”

Stella Duffy questions the booming menopause market, says it feeds on ageist culture, and argues for valuing older women's bodies and life after menopause.

Opinion
#4
Getting care
76%

of women who discussed symptoms with a practitioner had to bring up perimenopause themselves. Only 21% said their practitioner raised it first.

Brand survey
#3
At work
4.6%

of 217 Canadian women physicians surveyed had ever taken time off for menopause symptoms, though about 40% felt their work performance suffered.

Peer-reviewed
#2
Body & timing
57%

more likely to log hot flashes in the Oura app: members aged 45 to 54, by Oura's own count. Oura does not say who they are compared with or how many members it counted.

Company data
#1
Getting care
48%

of women in the same Indian survey said they would take treatment if a practitioner offered it.

Peer-reviewed